TA and TL in myeloma cells and normal plasma cells
. | TA, % of neuroblastoma cell line control . | . | . | . | TL, kbp . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | N . | Median . | Min . | Max . | N . | Median . | Min . | Max . | ||||||
| Myeloma patients | 183 | 8.0 | 0.02 | 426.8 | 115 | 5.6 | 3.0 | 15.0 | ||||||
| Diagnosed | 86 | 6.3 | 0.02 | 325.3 | 55 | 6.6 | 3.2 | 15.0 | ||||||
| Relapsed | 97 | 16.2 | 0.07 | 426.8 | 60 | 5.3 | 3.0 | 13.4 | ||||||
| MM cell lines | 5 | 180.1 | 86.6 | 265.8 | 5 | 3.7 | 1.7 | 8.6 | ||||||
| Healthy donors | 7 | 3.7 | 0.3 | 22.5 | 7 | 10.6 | 9.6 | 11.3 | ||||||
. | TA, % of neuroblastoma cell line control . | . | . | . | TL, kbp . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | N . | Median . | Min . | Max . | N . | Median . | Min . | Max . | ||||||
| Myeloma patients | 183 | 8.0 | 0.02 | 426.8 | 115 | 5.6 | 3.0 | 15.0 | ||||||
| Diagnosed | 86 | 6.3 | 0.02 | 325.3 | 55 | 6.6 | 3.2 | 15.0 | ||||||
| Relapsed | 97 | 16.2 | 0.07 | 426.8 | 60 | 5.3 | 3.0 | 13.4 | ||||||
| MM cell lines | 5 | 180.1 | 86.6 | 265.8 | 5 | 3.7 | 1.7 | 8.6 | ||||||
| Healthy donors | 7 | 3.7 | 0.3 | 22.5 | 7 | 10.6 | 9.6 | 11.3 | ||||||
Min indicates minimum; and max, maximum.